Popular Covid-19 At-Home Tests and How to Use Them (Part II)

Annie Spratt/Unsplash

Part II of our article series reviews popular COVID-19 At-Home tests and how they are used.

BinaxNOW (BinaxNOW COVID-19 Ag Card Home Test)

Approved in December 2020, BinaxNow  2020  is a prescription-based at-home test for patients 15 years old and older. According to the label, BinanaxNow can also be used for children from four years old once a child shows symptoms of the disease. You should take two tests 36 hours apart to get an accurate result as per directions.

BinaxNOW can detect traces of the new variants of COVID-19, including Delta and Omicron. With a price tag currently at around $15, it is one of the most affordable COVID-19 at-home tests. However, as of this writing, the over-the-counter version of BinaxNOW has not been approved by CDC for travel authorization.

QuickVue (Quidel QuickVue At-Home COVID-19 Test)

Approved by the FDA in March 2021, QuickVue is the fastest COVID self-test that provides a result within ten minutes. However, performing at least two tests 35 hours apart is also recommended for the most accurate results.

QuickVue test is authorized for prescription home use for individuals over 14 years of age within the first six days of COVID-19 symptoms onset.

Lucira (Lucira COVID-19 All-In-One Test Kit)

FDA approved this test in November 2020, which makes it the first officially recognized COVID self-testing kit

Lucra is the only at-home test that uses molecular technology. It means that the test can actually recognize some of the virus`s genetic material. However, it still belongs to the group of Antigen COVID Testing.

For now, the Lucra home testing kit is authorized for prescription use for patients over 14 years of age who demonstrated symptoms of COVID-19. According to the Community Testing Study, the Lucra Testing Kit provides up to 94% accurate results. 

Using COVID At-home testing kits

Covid At-home tests are simple to use. But while it is a simple process, it is essential that you follow the official guidelines and manufacturers` instructions to ensure that the results you receive from a COVID self-testing kit are credible. The guide below is to give you an idea of what to expect. Again, follow the manufacturer’s directions:

Preparation

Wash your hands thoroughly for at least 20 seconds.

Open the box and read the instructions carefully.

Collect the nasal swab or saliva sample carefully and according to the guidelines to guarantee an indicative result.

Testing

Once you collect the sample, perform the test according to the manufacturer`s instructions.

Result

  A Positive Result

Isolate for 10 days and wear a mask if you have to be in physical contact with other people.

Inform your healthcare provider about a positive result and follow the official guidelines.

Inform people who have been in close contact with you within the past 48 hours that they might have been exposedto the virus.

  A Negative Result

If you have no symptoms, most manufacturers recommend performing another test after 36 hours to confirm the result.

If you have symptoms, contact your healthcare provider, because the result may be false, or you may have another disease with symptoms similar to those caused by COVID-19.

  An Invalid Result 

Such cases are rare and may be caused by a manufacturer`s defect or incorrect testing. If the test appears invalid, make sure to perform another testing according to the manufacturer’s instructions right away. 

.

What You Need to Know About COVID At-Home Tests and Self Testing (Part 1)

Steve Normax/Unsplash

According to CDC (Centers for Disease Control and Prevention), COVID self-testing, which is also often referred to as “at-home testing,” is one of the strategies that helps to reduce the risk of COVID-19 transmissions

You can perform these tests at home before going to school, work, or any social gathering to make sure that you are not infected at the moment. They are purchased over-the-counter from your pharmacy or retailer. They also are easy to use and are equally indicative regardless of your vaccination status or the presence or absence of COVID-19 symptoms.

This is the first of two articles aimed to address the most common questions about COVID self-testing and to provide the most current and relevant information about available at-home tests and their use.

.

.

How do COVID-19 At-Home tests work?

At-home tests come in a safe and convenient form of nasal swabs, which can be done anywhere. They can provide a result within 15-30 minutes. Because they are quick and convenient, these tests are also known as rapid tests.

All currently approved COVID self-tests are the “antigen tests” you hear about in the media. It means that they can detect the materials that a virus can leave behind, for example, the proteins. They don`t, however, recognize the virus`s actual generic material. Technically, it is like seeing animal fur on furniture and assuming a pet in the house.

.

What is the difference between a PCR and Antigen COVID test?

Both PCR and Antigen testing start with a sample from the patient or participant. It can be a nasal swab or saliva sample.

However, PCR testing aims to detect the virus`s DNA in the sample through a polymerase chain reaction technique. This kind of testing provides a more accurate and definitive result but requires special equipment and a skilled lab technician to run them properly.

Antigen tests use lab-made antibodies to search for antigens from the SARS-CoV-2 virus. Those are the substances that force our immune system to produce antibodies. The testing strip used in such tests binds to the antigen in a sample and indicates it with a colored stripe.

Antigen tests (i.e., rapid tests) are faster and easier to perform, but they are less sensitive and accurate than PCR testing. In other words, if the accuracy of PCR COVID tests approaches 100%, Antigen home testing, by comparison, identifies the infection in 72% of people with symptoms and 58% of people without symptoms.

How much do COVID At-home testing kits cost?

When COVID self-testing kits were first introduced to the general public, costs ranged between $25 and $50.   Currently, several brands of Antigen tests are available for about $20. Costs are higher for PCP tests

Self-testing kits may likely follow a similar price pattern as facemasks, which skyrocketed in price at the beginning of the pandemic, only to come down significantly and be made available to individuals in need of them in healthcare clinics and public places.

According to the latest statements of President Biden`s Administration, Americans will get access to over 150 million free home-testing kits during the holiday season. The tests will be available through local libraries, schools, and healthcare facilities.  

But before you head to your local library, it is recommended that participants call ahead because these facilities have limited storage space, and products are delivered in batch amounts. If the library doesn’t have a kit available and you cannot get to a facility to be tested, rapid kits can still be purchased from a retailer, such as your local pharmacy.

In addition, retail giants such as Walmart and Amazon announced the possible launch of low-cost COVID self-testing kits for travelers during the holiday season. You can purchase a single kit or a multipack containing several kits so you can use them as needed for yourself or to give to family members.

In the next article we will discuss the most popular at-home tests and how to use them.

.

Third Vaccine Approved for Emergency Use Against Covid-19

Single Shot and No Extreme Refrigeration Needed

The Food and Drug Administration (FDA) has approved a third vaccine for Emergency Use Authorization against Covid-19 for individuals 18 years old and older.

The FDA has determined the Janssen Covid-19 vaccine, produced by Johnson and Johnson, has met the statutory criteria for emergency use authorization, or EUA, and approved the vaccine on February 27, 2021. This vaccine requires only a single injection instead of the two injections required by Pfizer-BioNTech and Moderna. In clinical trials, it was 100% effective against severe Covid-19 and death and 72% effective against Covoid-19. Although the latter rate is lower than the other two vaccines, it is still considered very effective, based on standards set by the FDA.

Also, this vaccine does not require extreme cold refrigeration like the Pfizer and Moderna vaccines. This is good news for community clinics and rural areas previously unequipped to handle the storage requirements.

Updated: Rollout is expected to begin as early as Monday.

Comparison between Pfizer and Moderna COVID-19 Vaccines Authorized in the U.S.

The U.S. Food and Drug Administration (FDA) has recently approved COVID-19 vaccines. They come from two leading laboratories in the field – the Pfizer-BioNTech and Moderna.

Both vaccines use the same technology, known as mRNA, and teach your body to provide an adequate immune response to COVID-19 without using the live virus that causes it.

However, there are some significant differences between the two vaccines regarding their storage and the overall vaccination process logistics.

Storage temperature

  • Pfizer-BioNTech – has to be stored in less than -94o F and can stay in a regular fridge for up to 5 days
  • Moderna – Requires -4o F storage temperature and can remain in a standard fridge up to 30 days

Preparation

  • Pfizer-BioNTech – requires dilution with salt water (saline)
  • Moderna – ready-to-use

Vaccination age range

  • Pfizer-BioNTech – 16 y.o. +
  • Moderna – 18 y.o. +

Shots required

  • Pfizer-BioNTech – 2 shots, 21 days apart
  • Moderna – 2 shots, 28 days apart

Side effects

Both Pfizer-BioNTech and Moderna vaccines demonstrate similar character and frequency of side effects. Those are pain at the injection site, followed by tiredness, headache, muscle pain, joint pain, and chills. Several patients reported severe allergic reactions. However, all of them had a history of allergies to certain components of the vaccine.

 

COVID-19 Vaccination for the Older Americans: Anticipated Timeframe and Perspectives

The first COVID-19 vaccines became available in the US by the end of 2020. However, because of poor logistics and administration, fewer than 10 million people had received their first doses by the middle of January 2021.
Due to the current shortage in the available doses and uneven demographics from state to state, vaccination priorities remain unclear in most of the country.


The Centers for Disease Control and Prevention (CDC) recommends prioritizing elderly citizens (75 y.o. +) as well as healthcare frontline and essential workers in the first wave of vaccination. However, vague instruction and a lack of federal guidance have led to confusion about vaccination priorities and perspectives.

The vaccination forecasts remain uncertain due to shipment and logistics issues. The limitations over healthcare workers and facilities that receive the vaccine are another crucial deterrent. As a result, most experts predict vaccination of the general public will not be possible until Summer 2021.
Still, not all American citizens are willing to get vaccinated immediately. According to the recent poll, 54% of older Americans would prefer to wait and see how others respond to the doses first.


At the same time, the efficiency of vaccination depends on the widespread participation of the public. Experts claim that the disease can`t be defeated until 90% of the population gets vaccinated.


That is why most state officials consider launching educational campaigns to explain the effect and importance of vaccination. But the pandemic has impacted most fiscal budgets, making these campaign initiatives tougher to implement.

USFDA Advisory Committee Meets to Discuss and Vote on Pfizer Vaccine for Emergency Approval

With the United Kingdom’s recent rollout of the Pfizer/BionTech Covid-19 vaccine, and Canada expecting to follow suit before the end of December, the U.S. Food and Drug Administration will meet today on whether the vaccine should be approved for use in the U.S.

The meeting consists of a panel of outside experts that advises the government. The experts will discuss the efficacy of the vaccine in terms of safety and effectiveness. One of the issues that is likely to be discussed is adverse allergic events and how to address them, after two nurses in the UK had severe allergic reactions to the vaccine.

There also will be a public hearing, followed by a committee discussion and vote.  The meeting is expected to take the entire day.

If the FDA clears the drug for use, the rollout for administration  could come as early next week.

Two UK Nurses Presented with Severe Allergic Reactions Following Administration of the Pfizer Covid-19 Vaccine

Just a day after the United Kingdom implemented its national rollout of the Pfizer/ Covid-19 vaccine, health officials warn people with a history of severe allergic reactions not to participate. This warning came after two nurses suffered an allergic reaction to the vaccine.

The nurses experienced an “anaphylactoid” reaction characterized by rashes and shortness of breath. Both nurses have a history of allergic reactions and carry an EpiPen, which is a device that looks like a fat pen and delivers a dose of epinephrine. People with severe allergic reactions keep EpiPens nearby for emergency use. Both nurses recovered quickly.

The UK health officials reacted immediately with the following guidance: those with significant allergies to food, medicine, and vaccines, should not take the Pfizer vaccine. There are no preservatives in the vaccine, so more studies will be needed to determine possible causes since the clinical trials did not study individuals with a history of severe allergies.

As other companies are also producing a Covid-19 vaccine, people with severe allergic reactions may tolerate one of the other vaccines. Meanwhile, in the US, the Food and Drug Administration will convene an expert panel meeting on December 10, 2020, to determine if emergency use of the Pfizer vaccine should be approved, given its high effectiveness rate. If approved, health officials are likely to disseminate similar warnings.

A Breakthrough for the Most Serious Patients Affected by COVID-19

Drug is Available Worldwide and Inexpensive

There appears to be a significant breakthrough in the fight against COVID-19, and it comes in the form of a relatively inexpensive drug that has been available worldwide for years.


British scientists at Oxford University report Dexamethasone has reduced death rates by 35% for patients on ventilators and by 20% for those on oxygen.


Dexamethasone is a generic steroid that’s been used for 60 years to reduce inflammation in conditions such as arthritis and asthma. It is inexpensive, costing about one dollar per day in the U.S. and in many other parts of the world.

To date, it is the only drug that has shown to reduce mortality. However, the scientists noted that the drug does not appear to help patients with milder Coronavirus symptoms and who are not experiencing breathing problems.

Still, the findings represent a significant breakthrough in trial research. There has been a worldwide race to find a vaccine or cure for COVID-19, which has affected more than 8 million people and is responsible for more than 430,000 worldwide, as of this writing. Researchers remain hopeful about Remdesivir, an anti-viral drug created to fight Ebola, shown thus far, to reduce the duration of severe COVID-19 symptoms from 15 to 11 days.

Findings from the Oxford research study are in the process of being published.

Updates on this research will be published here.

Earth Day 2020

April 22nd marks the 50th anniversary of Earth Day, a day that is celebrated all over the planet. The environmental movement is one of its many successful byproducts.

Unfortunately, due to the COVID-19 pandemic, we cannot share our celebration with the world–at least not physically. This year, events will be digital. The theme is Climate Change, and there will be 24 hours of Earth Day events, including online conversations, calls to action, performances, and video teach-ins. Visit EarthDay.org to find out what’s happening in your area and online.

Why We Can’t Seem to Stop Touching Our Faces (And a Few Tips That Should Help)

In the days following the COVID-19 outbreak, public health experts have warned us against touching our faces. For the vast majority, this is easier said than done. Even under the threat of becoming seriously ill, people still have momentary lapses in judgment. Why is that? Is it possible to make ourselves stop? Here are some takeaways to explain why we do this, and what can be done to reduce, and maybe overcome, what is now officially deemed an annoying and dangerous habit.

Causes

Nothing seems more natural than touching your face. We often touch our faces because it’s a simple reaction to a stimulus, like rubbing away sleep from our eyes or holding our nostrils together to  prevent a sneeze, or wiping our mouths with our unwashed hands.  In other words, touching our face is often done simply out of reflex.

Research shows that we begin touching our faces at an early age. A fetus is capable of touching its head, face, and even sucking its thumb. And as soon as we are aware of our reflection, we can’t seem to stop touching our faces. We pick at pimples, tweeze our brows, and make-up our faces to perfection.  

But touching our faces isn’t always a simple reflex. Facial touching can also be a nonverbal way of communicating. At the end of her comedy show, Carol Burnett would tug at her earlobe to signal to her grandmother that things were going well. A person might also brush or pinch the tip of their nose, stroke their chin, or rub their forehead to indicate they are processing information.

Face touching can also be a reaction to stress and frustration. The stress reaction could stem from a variety of situations and can be either good or bad. It could be a Home Alone palms-to-face panic moment, an exhilarating “I just won the lottery!” moment, or an “I am utterly embarrassed” face-in-hands moment. Body language experts suggest it could also be an “I’m lying to you” moment.

In certain instances, facial touching is a way to feel a sense of comfort or to self-soothe. And when a behavior is repeated often enough it becomes a learned response. The basal ganglia (a part of the brain that affects movement) takes over, and the behavior becomes instinctive. As a result, you end up touching your face absentmindedly.

People are simply unaware of how frequently they touch their faces, even when they know its potential consequences. An observational study at the University of South Wales found that a group of medical students touch their faces 23 times an hour, despite knowing it would transfer germs.

Tips for What You Can Do

Keep Track. By increasing your awareness, you will gain insight into how frequently you touch your face and when it occurs. Just the act of self-monitoring can reduce its frequency. Start by partitioning your day into segments (e.g., morning, afternoon, and evening). At the end of each segment, count the frequency and determine the grand total.

Get a Buddy. Having a buddy tell you when you are touching your face will ensure your count is accurate and help reduce the behavior by calling immediate attention to it.

Recite an Affirmation. At the start of each segment, tell yourself that you are going to change your behavior. But keep your goals small and specific. For example, if you declare, “I’m going to totally STOP touching my face,” chances are you won’t succeed. You’ll get frustrated and give in after a few days. Instead, you might say, “I’m going to decrease the number of times I touch my face by X.” Aim for reduction first, then total elimination.  

Inject Imagery. Have a good imagination? Think about the nasty things you touch all day that are loaded with germs and viruses (your electronic devices, door handles, steering wheel, keys, toilet handle, someone else’s pen, money, etc.) and if you want that stuff on your face. Just being mindful will help reprogram your brain so you will become more aware of what you’re doing to your face.

Try (Positive) Distractions. Nervous hands? Distract them in a way that would result in positive (not negative) consequences. Going for a bag of chips because it keeps your hands busy would be a negative distraction. Instead, a positive distraction, like a rubber squeeze ball, can be used to keep hands occupied and doesn’t cost unwelcome calories. If you don’t have one, try a pencil or pen, or a toy or gadget like a Rubik’s Cube. (I received a gift of worry beads once.) You might also consider hand and finger exercises to reduce tension. For example, make a fist, then spread your fingers wide for 30-60 seconds. Repeat four times on each hand.

Apply Reinforcement Principles. An old-fashioned reinforcement technique I’ve used successfully calls for wearing a rubber band and snapping it on the inside of my wrist. If I touched my face, I would snap the rubber band just enough to sting slightly. The purpose is to associate the temporary discomfort with the undesirable behavior (face touching). I would use the skinniest, lightest, and most flexible rubber band available, one that will hang loosely over the wrist and stretch about 2-3 inches.  

If you find that a bit punitive, the purpose is not to inflict red and blue marks that can be seen from ten feet away. If you wish, you can also incorporate positive reinforcement—a reward—at the end of each day if you’ve met your daily goal reduction.

For the Tech Savvy

Technology has come to the rescue for those who think manual counting is too much work (although the activity itself can be motivating). There’s a device you can wear on your wrist to monitor the number of times you touch your face. When that happens the device will vibrate. It was developed initially for people suffering from trichotillomania, a disorder that compels a person to pull out their hair. But the goal is the same: decrease frequency by increasing awareness.

Not Going Well? Forgive, Analyze, and Try Again

If your interventions don’t seem to be working, don’t be hard on yourself. After all, this is a difficult habit to break. Carefully examine your triggers. Could you be stressed or bored? Is it more likely to happen when you’re at work? Is there an environmental factor, like an allergy?

Once you identify the cause(s), make whatever adjustments you can. For nervous hands, try a competing activity (something you can do that will physically prevent you from touching your face), such as sitting on your hands for 30 seconds or more. When I’m working on my laptop, for example, or trying to solve a complex problem, I’m more likely to touch my face. So I might 1) sit on my hands for 30 seconds; 2) make fists and open and close them five times; 3) take a couple minutes away from my desk; or, as a last resort, 4) use the rubber band technique.

Remember, no one is perfect, and you will slip up along the way. When you do, acknowledge your mistake and keep going. As part of your COVID-19 response, use the “I goofed” opportunity to do something right, like putting on some hand sanitizer or washing your hands if possible. Then pick up where you left off.

Suffice it to say, if you can avoid touching your face, you are likely to prevent catching a host of other viruses, like the common cold, the seasonal flu, and the “24-hour bugs” that get passed around at work. And once you are successful, make it your new normal for your and others’ health.